Carl Zeiss Meditec AG (AFX.F)

Compare

47.92

-3.58

(-6.95%)

As of 1:19:47 PM GMT+2. Market Open.

ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach

ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration (NMPA) approval in China, marking a significant milestone in the product's global journey.

PR Newswire 8 days ago

CZMWF

CZMWY
Carl Zeiss Meditec AG (ETR:AFX) Stock Goes Ex-Dividend In Just Three Days

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Simply Wall St. 12 days ago

CZMWF

CZMWY
Carl Zeiss Meditec's (ETR:AFX) Dividend Will Be Reduced To €0.60

Carl Zeiss Meditec AG ( ETR:AFX ) has announced that on 31st of March, it will be paying a dividend of€0.60, which a...

Simply Wall St. 13 days ago

CZMWF

CZMWY
ZEISS Introduces VISULAS Combi in Canada; a Revolutionary Therapeutic Laser Workstation for Enhanced Eye Care

ZEISS Medical Technology announced today the availability in Canada of the ZEISS VISULAS Combi, an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp technology in a single, comprehensive solution. Designed for the treatment of retina, cataract, and glaucoma conditions, the ZEISS VISULAS Combi streamlines workflows with customizable modules, a uniform interface, and space-saving features. It enables seamless eye care without the need for time-consumi

CNW Group 13 days ago

CZMWF

CZMWY
European Market's Hidden Gems: ASML Holding And 2 Other Value Stocks

In the midst of economic uncertainties and fluctuating indices, the European market has been navigating challenges such as U.S. trade tariffs and monetary policy shifts, with major stock indexes showing mixed performances. Despite these hurdles, opportunities arise for discerning investors to identify undervalued stocks that may offer potential value in a volatile environment.

Simply Wall St. 18 days ago

ASML

ASMLF

EADSF
When Should You Buy Carl Zeiss Meditec AG (ETR:AFX)?

Carl Zeiss Meditec AG ( ETR:AFX ), is not the largest company out there, but it saw a significant share price rise of...

Simply Wall St. 25 days ago

CZMWF

CZMWY
ZEISS VISUMAX 800 with SMILE pro software receives approval in China

ZEISS Medical Technology announced today that the National Medical Products Administration (NMPA) in China has approved the VISUMAX® 800 with SMILE® pro software from ZEISS for surgically treating nearsightedness, with or without astigmatism. The latest generation of femtosecond lasers from ZEISS enters the China market at a time when more than 10 million eyes have been treated with ZEISS SMILE and SMILE pro worldwide, reflecting the technology's broad global momentum driven by strong adoption i

PR Newswire last month

CZMWF

CZMWY
Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Smaller Dividend Than Last Year

Carl Zeiss Meditec AG's ( ETR:AFX ) dividend is being reduced from last year's payment covering the same period to...

Simply Wall St. last month

CZMWF

CZMWY
Carl Zeiss Meditec AG (CZMWF) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Market ...

Despite revenue growth and strategic advancements, Carl Zeiss Meditec AG (CZMWF) faces margin pressures and market uncertainties, particularly in China.

GuruFocus.com last month

CZMWY
The past three years for Carl Zeiss Meditec (ETR:AFX) investors has not been profitable

Carl Zeiss Meditec AG ( ETR:AFX ) shareholders should be happy to see the share price up 21% in the last month. But...

Simply Wall St. last month

CZMWF

CZMWY
$ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow$

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia and mixed astigmatism (a condition where both hyperopic and myopic correction is required). The ZEISS MEL 90 fully integrates into the Corneal Refractive Workflow to offer U.S. surgeons a fast, reliable, and streamlined surgery experience, complementing t

PR Newswire 2 months ago

CZMWF

CZMWY
An Intrinsic Calculation For Carl Zeiss Meditec AG (ETR:AFX) Suggests It's 41% Undervalued

Key Insights The projected fair value for Carl Zeiss Meditec is €77.77 based on 2 Stage Free Cash Flow to Equity Carl...

Simply Wall St. 3 months ago

CZMWF

CZMWY
Carl Zeiss Meditec AG Just Beat EPS By 11%: Here's What Analysts Think Will Happen Next

There's been a notable change in appetite for Carl Zeiss Meditec AG ( ETR:AFX ) shares in the week since its yearly...

Simply Wall St. 3 months ago

CZMWF

CZMWY
Carl Zeiss Meditec Full Year 2024 Earnings: EPS Beats Expectations

Carl Zeiss Meditec ( ETR:AFX ) Full Year 2024 Results Key Financial Results Revenue: €2.07b (down 1.1% from FY 2023...

Simply Wall St. 3 months ago

CZMWF

CZMWY
Carl Zeiss Meditec AG (CZMWF) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...

Despite a challenging fiscal year, Carl Zeiss Meditec AG (CZMWF) leverages new product launches and strategic market positioning to drive future growth.

GuruFocus.com 3 months ago

CZMWY
German company Zeiss opens global capability centre in India

The company aims to double its workforce in India to 5,000 within three years.

Verdict 4 months ago

CZMWY
Carl Zeiss Meditec (ETR:AFX) Will Be Hoping To Turn Its Returns On Capital Around

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...

Simply Wall St. 4 months ago

CZMWF

CZMWY
Is Carl Zeiss Meditec AG's (ETR:AFX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Most readers would already be aware that Carl Zeiss Meditec's (ETR:AFX) stock increased significantly by 19% over the...

Simply Wall St. 5 months ago

CZMWF

CZMWY
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions

ZEISS Medical Technology will showcase digital enhancements and revolutionary surgical solutions at the American Academy of Ophthalmology (AAO) conference from Oct. 19-21, 2024, in Chicago. These innovations across cataract, corneal refractive, retina, and glaucoma workflows, offer new, enhanced paths to patient management and treatment, using a digitally connected environment to help advance the clinical workflow to support a higher level of personalized care.

CNW Group 5 months ago

CZMWF

CZMWY
ZEISS introduces its latest Robotic Visualisation System for neuro surgery

At this year's Congress of Neurological Surgeons (CNS) in Houston, Texas, USA, ZEISS Medical Technology launches the KINEVO® 900 S. The latest Robotic Visualization System® is a further development of the successful ZEISS KINEVO 900 platform. With best digital visualization, collaborative assistant functions and connected intelligence, ZEISS KINEVO 900 S offers more clarity for complex surgical procedures in neurosurgery and other surgical disciplines.

PR Newswire 5 months ago

CZMWF

CZMWY

Performance Overview

Return	AFX.F	DAX P (^GDAXI)
YTD	+5.32%	+3.73%
1-Year	-55.51%	+12.22%
3-Year	-67.48%	+42.24%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Carl Zeiss Meditec AG (AFX.F)

ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach

Carl Zeiss Meditec AG (ETR:AFX) Stock Goes Ex-Dividend In Just Three Days

Carl Zeiss Meditec's (ETR:AFX) Dividend Will Be Reduced To €0.60

ZEISS Introduces VISULAS Combi in Canada; a Revolutionary Therapeutic Laser Workstation for Enhanced Eye Care

European Market's Hidden Gems: ASML Holding And 2 Other Value Stocks

When Should You Buy Carl Zeiss Meditec AG (ETR:AFX)?

ZEISS VISUMAX 800 with SMILE pro software receives approval in China

Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Smaller Dividend Than Last Year

Carl Zeiss Meditec AG (CZMWF) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Market ...

The past three years for Carl Zeiss Meditec (ETR:AFX) investors has not been profitable

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

An Intrinsic Calculation For Carl Zeiss Meditec AG (ETR:AFX) Suggests It's 41% Undervalued

Carl Zeiss Meditec AG Just Beat EPS By 11%: Here's What Analysts Think Will Happen Next

Carl Zeiss Meditec Full Year 2024 Earnings: EPS Beats Expectations

Carl Zeiss Meditec AG (CZMWF) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...

German company Zeiss opens global capability centre in India

Carl Zeiss Meditec (ETR:AFX) Will Be Hoping To Turn Its Returns On Capital Around

Is Carl Zeiss Meditec AG's (ETR:AFX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions

ZEISS introduces its latest Robotic Visualisation System for neuro surgery

Performance Overview